19258-73-2

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 2-AMINO-4,5-DIMETHYL-BENZOATE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic properties.
Used in Organic Synthesis:
In the field of organic synthesis, METHYL 2-AMINO-4,5-DIMETHYL-BENZOATE serves as a building block, facilitating the creation of a wide range of organic compounds due to its reactive functional groups.
Used in Agricultural Industry:
METHYL 2-AMINO-4,5-DIMETHYL-BENZOATE is utilized as a chemical intermediate in the development of agrochemicals, potentially contributing to the production of pesticides or other agricultural products that enhance crop protection and yield.
Used in Chemical Industry:
METHYL 2-AMINO-4,5-DIMETHYL-BENZOATE is also employed in the chemical industry for various applications, leveraging its structural and reactive attributes to produce a spectrum of chemical products for diverse uses.

InChI:InChI=1/C10H13NO2/c1-6-4-8(10(12)13-3)9(11)5-7(6)2/h4-5H,11H2,1-3H3

Upstream product

• 15089-51-7 2-amino-4,5-dimethylbenzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 67-56-1 methanol 

Relevant academic research and scientific papers

NONMUSCLE MYOSIN II INHIBITORS FOR SUBSTANCE USE RELAPSE

The invention can provide compounds, analogs of blebbistatin, effective and selective inhibitors of nonmuscle myosin II relative to cardiac myosin II. Compounds can be used in the method of treating a disease, disorder, or medical condition in a patient, comprising modulating myosin II ATPase, such as treatment of substance abuse relapse disorder, or of renal disease, cancer and metastasis, benign prostate hyperplasia, hemostasis or thrombosis, nerve injury including retinal damage, lung fibrosis, liver fibrosis, arthrofibrosis, wound healing, spinal cord injury, periodontitis, glaucoma and immune-related diseases including multiple sclerosis; or wherein the disease, disorder, or medical condition comprises addiction including abuse of or addiction to anything classified as a Substance-Related or Addictive Disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM), such as, but not limited to, cocaine, opioids, amphetamines, ethanol, cannabis/marijuana, nicotine, and activities including gambling Compounds are of general formula (I) with substituents as defined herein.

N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors

Described are compounds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10-(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of